The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: An evidence-based review

Ross Arena, Jonathan Myers, Marco Guazzi

Research output: Contribution to journalArticle

Abstract

A hallmark symptom of heart failure (HF) is exercise intolerance, typically evidenced by excessive shortness of breath, and/or fatigue with exertion. In recent years, the physiologic response to progressive exercise using direct measures of ventilation and gas exchange, commonly termed the cardiopulmonary exercise test (CPX), has evolved into an important clinical tool in the management of patients with HF. There is currently debate regarding the optimal CPX response to apply when stratifying risk for mortality, hospitalization, or other outcomes in patients with HF. Early studies in this area focused on the application of peak VO2 in predicting outcomes in patients considered for transplantation. More recently, the focus of these studies has shifted to an emphasis on ventilatory inefficiency, in lieu of or in combination with peak VO2, in estimating risk. The most widely studied index of ventilatory inefficiency has been the minute ventilation/carbon dioxide production (VE/VCO2) slope. A growing body of studies over the last decade has demonstrated that among patients with HF, the VE/VCO2 slope more powerfully predicts mortality, hospitalization, or both, than peak VO2. A number of investigations have also simultaneously examined the diagnostic importance of peak VO2 and the VE/VCO2 slope as well as their respective response to various interventions. This review examines the body of evidence which has used aerobic capacity and ventilatory efficiency as prognostic and diagnostic markers as well as endpoints in interventional trials. Based on this evidence, recommendations for future clinical and research applications of these CPX variables are provided.

Original languageEnglish
Pages (from-to)245-269
Number of pages25
JournalHeart Failure Reviews
Volume13
Issue number2
DOIs
Publication statusPublished - Jun 2008

Fingerprint

Heart Failure
Research
Ventilation
Hospitalization
Exercise
Mortality
Exercise Test
Carbon Dioxide
Dyspnea
Fatigue
Transplantation
Gases

Keywords

  • Diagnosis
  • Exercise test
  • Intervention
  • Prognosis
  • Ventilatory expired gas

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure : An evidence-based review. / Arena, Ross; Myers, Jonathan; Guazzi, Marco.

In: Heart Failure Reviews, Vol. 13, No. 2, 06.2008, p. 245-269.

Research output: Contribution to journalArticle

@article{cf746517ad7845d985380ea913554956,
title = "The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: An evidence-based review",
abstract = "A hallmark symptom of heart failure (HF) is exercise intolerance, typically evidenced by excessive shortness of breath, and/or fatigue with exertion. In recent years, the physiologic response to progressive exercise using direct measures of ventilation and gas exchange, commonly termed the cardiopulmonary exercise test (CPX), has evolved into an important clinical tool in the management of patients with HF. There is currently debate regarding the optimal CPX response to apply when stratifying risk for mortality, hospitalization, or other outcomes in patients with HF. Early studies in this area focused on the application of peak VO2 in predicting outcomes in patients considered for transplantation. More recently, the focus of these studies has shifted to an emphasis on ventilatory inefficiency, in lieu of or in combination with peak VO2, in estimating risk. The most widely studied index of ventilatory inefficiency has been the minute ventilation/carbon dioxide production (VE/VCO2) slope. A growing body of studies over the last decade has demonstrated that among patients with HF, the VE/VCO2 slope more powerfully predicts mortality, hospitalization, or both, than peak VO2. A number of investigations have also simultaneously examined the diagnostic importance of peak VO2 and the VE/VCO2 slope as well as their respective response to various interventions. This review examines the body of evidence which has used aerobic capacity and ventilatory efficiency as prognostic and diagnostic markers as well as endpoints in interventional trials. Based on this evidence, recommendations for future clinical and research applications of these CPX variables are provided.",
keywords = "Diagnosis, Exercise test, Intervention, Prognosis, Ventilatory expired gas",
author = "Ross Arena and Jonathan Myers and Marco Guazzi",
year = "2008",
month = "6",
doi = "10.1007/s10741-007-9067-5",
language = "English",
volume = "13",
pages = "245--269",
journal = "Heart Failure Reviews",
issn = "1382-4147",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure

T2 - An evidence-based review

AU - Arena, Ross

AU - Myers, Jonathan

AU - Guazzi, Marco

PY - 2008/6

Y1 - 2008/6

N2 - A hallmark symptom of heart failure (HF) is exercise intolerance, typically evidenced by excessive shortness of breath, and/or fatigue with exertion. In recent years, the physiologic response to progressive exercise using direct measures of ventilation and gas exchange, commonly termed the cardiopulmonary exercise test (CPX), has evolved into an important clinical tool in the management of patients with HF. There is currently debate regarding the optimal CPX response to apply when stratifying risk for mortality, hospitalization, or other outcomes in patients with HF. Early studies in this area focused on the application of peak VO2 in predicting outcomes in patients considered for transplantation. More recently, the focus of these studies has shifted to an emphasis on ventilatory inefficiency, in lieu of or in combination with peak VO2, in estimating risk. The most widely studied index of ventilatory inefficiency has been the minute ventilation/carbon dioxide production (VE/VCO2) slope. A growing body of studies over the last decade has demonstrated that among patients with HF, the VE/VCO2 slope more powerfully predicts mortality, hospitalization, or both, than peak VO2. A number of investigations have also simultaneously examined the diagnostic importance of peak VO2 and the VE/VCO2 slope as well as their respective response to various interventions. This review examines the body of evidence which has used aerobic capacity and ventilatory efficiency as prognostic and diagnostic markers as well as endpoints in interventional trials. Based on this evidence, recommendations for future clinical and research applications of these CPX variables are provided.

AB - A hallmark symptom of heart failure (HF) is exercise intolerance, typically evidenced by excessive shortness of breath, and/or fatigue with exertion. In recent years, the physiologic response to progressive exercise using direct measures of ventilation and gas exchange, commonly termed the cardiopulmonary exercise test (CPX), has evolved into an important clinical tool in the management of patients with HF. There is currently debate regarding the optimal CPX response to apply when stratifying risk for mortality, hospitalization, or other outcomes in patients with HF. Early studies in this area focused on the application of peak VO2 in predicting outcomes in patients considered for transplantation. More recently, the focus of these studies has shifted to an emphasis on ventilatory inefficiency, in lieu of or in combination with peak VO2, in estimating risk. The most widely studied index of ventilatory inefficiency has been the minute ventilation/carbon dioxide production (VE/VCO2) slope. A growing body of studies over the last decade has demonstrated that among patients with HF, the VE/VCO2 slope more powerfully predicts mortality, hospitalization, or both, than peak VO2. A number of investigations have also simultaneously examined the diagnostic importance of peak VO2 and the VE/VCO2 slope as well as their respective response to various interventions. This review examines the body of evidence which has used aerobic capacity and ventilatory efficiency as prognostic and diagnostic markers as well as endpoints in interventional trials. Based on this evidence, recommendations for future clinical and research applications of these CPX variables are provided.

KW - Diagnosis

KW - Exercise test

KW - Intervention

KW - Prognosis

KW - Ventilatory expired gas

UR - http://www.scopus.com/inward/record.url?scp=41249093511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41249093511&partnerID=8YFLogxK

U2 - 10.1007/s10741-007-9067-5

DO - 10.1007/s10741-007-9067-5

M3 - Article

C2 - 17987381

AN - SCOPUS:41249093511

VL - 13

SP - 245

EP - 269

JO - Heart Failure Reviews

JF - Heart Failure Reviews

SN - 1382-4147

IS - 2

ER -